Paul LaViolette
InvestorManaging Partner at SV Health Investors
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Paul LaViolette joined SV Health Investors in 2009 as a Venture Partner, became a Partner in 2011, and was named Managing Partner & COO in 2014, where he heads the firm's medical device investments. Before SV, he spent 15 years at Boston Scientific in roles including Chief Operating Officer and Group President, Cardiovascular, and earlier held marketing and general management positions at CR Bard and Kendall (Medtronic). He holds a BA in Psychology from Fairfield University and an MBA from Boston College.
Invests in
Digital HealthMedical Devices
Experience
- SpectraWAVE, Inc.Chairmancurrent2024 — present
- Pulse Biosciences, Inc.CEO and Co-Chairmancurrent2024 — present
- SV Health InvestorsManaging Partner & Chief Operating Officercurrent2008 — presentBoston
- Medtech Convergence FundManaging Partnercurrent2020 — presentBoston, Massachusetts, United States
- Vibrato Medical, Inc.Directorcurrent2022 — present
- Deerfield CatalystDirectorcurrent2022 — presentNew York, United States
- Edwards LifesciencesDirectorcurrent2020 — presentIrvine, California, United States
- Mass General Brigham InnovationChairmancurrent2016 — present
- CSA Medical IncDirectorcurrent2016 — presentLexington, Massachusetts, United States
- Corvia Medical, Inc.Chairmancurrent2012 — present
- Medical Device Manufacturers Association (MDMA)Director, Past Chairmancurrent2012 — present
- EndotronixChairman2017 — 2024
- Zerigo HealthDirector2019 — 2024
- StimwaveChairman2019 — 2022
- CardioFocusChairman2014 — 2022Marlborough, Massachusetts, United States
- Asensus SurgicalChairman2013 — 2021Morrisville, North Carolina, United States
- MisonixPast Chairman2020 — 2021
- Bardy Diagnostics, Inc.Past Lead Director2017 — 2021
- XimedicaPast Chairman2014 — 2021
- Boston ScientificCOO1994 — 2008
Education
- Boston College Carroll School of ManagementMBA1979 — 1981
- Fairfield UniversityBA, Psychology1975 — 1979
Skills & more
+12 more
HealthcareMarket DevelopmentBiotechnologyExecutive ManagementFinancial ModelingCorporate DevelopmentCross-functional Team LeadershipCompetitive AnalysisProduct LaunchCardiologyEntrepreneurshipProduct MarketingFrom Paul's professional profile.
Same school
Also attended Boston College Carroll School of Management45
+ 39 more
Also attended Fairfield University16
+ 10 more
Shared employers
Also worked at Edwards Lifesciences9
+ 3 more
Also worked at Zerigo Health1
Also worked at Bardy Diagnostics, Inc.4
Also worked at Boston Scientific29
+ 23 more
Deals · 12
Csa Medical IncBoard seat
via SV Health Investors · filed Jul 2026 · $11.2M raise
Lunair MedicalBoard seat
via SV Health Investors · filed Sep 2025 · $12.5M raise
Corvia MedicalBoard seat
via SV Health Investors · filed Jun 2025 · $11.1M raise
SpectrawaveBoard seat
via SV Health Investors · filed Oct 2024 · $50.3M raise
SkylitBoard seat
via SV Health Investors · filed Oct 2021 · $43M raise
Stimwave TechnologiesBoard seat
via SV Health Investors · filed Sep 2020 · $8M raise
CardioFocusBoard seat
via SV Health Investors · filed Jul 2020 · $15M raise
ValenTxBoard seat
via SV Health Investors · filed Aug 2018
EndotronixBoard seat
via SV Health Investors · filed Feb 2018 · $37.1M raise
TransEnterixBoard seat
via SV Health Investors · filed Sep 2017 · $950K raise
Direct Flow MedicalBoard seat
via SV Health Investors · filed Jul 2016 · $32.3M raise
Axon TherapiesBoard seat
via SV Health Investors · filed Apr 2016 · $2M raise
Attribution from SEC filings, press coverage, and firm rosters.





.jpeg)





























